These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 285458)

  • 21. [Isolation of Alternaria alternata in peritoneal fluid in patient in ambulatory chronic peritoneal dialysis].
    Megías G; Ojeda E; Pascual S; González B
    Enferm Infecc Microbiol Clin; 1997; 15(7):393-4. PubMed ID: 9410060
    [No Abstract]   [Full Text] [Related]  

  • 22. Keratomycosis due to Alternaria alternata corneal transplant infection.
    Ando N; Takatori K
    Mycopathologia; 1987 Oct; 100(1):17-22. PubMed ID: 3317059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New advances in antifungal treatment.
    Finquelievich JL; Odds FC; Queiroz-Telles F; Wheat LJ
    Med Mycol; 2000; 38 Suppl 1():317-22. PubMed ID: 11204159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous alternariosis.
    Romano C; Vanzi L; Massi D; Difonzo EM
    Mycoses; 2005 Nov; 48(6):408-12. PubMed ID: 16262877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
    Otcenásek M; Buchta V
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.
    Petrikkou E; Rodríguez-Tudela JL; Cuenca-Estrella M; Gómez A; Molleja A; Mellado E
    J Clin Microbiol; 2001 Apr; 39(4):1345-7. PubMed ID: 11283054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antifungal activity of extract and plumbagin from the stem bark of Diospyros crassiflora Hiern (Ebenaceae).
    Dzoyem JP; Tangmouo JG; Lontsi D; Etoa FX; Lohoue PJ
    Phytother Res; 2007 Jul; 21(7):671-4. PubMed ID: 17444575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological activity of sulphur ylides. I. Antimicrobial properties of some new carbonyl stabilized sulphonium ylides.
    Reddy GR; Reddy GR; Sarada S
    Biochem Int; 1989 Aug; 19(2):215-8. PubMed ID: 2684160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal combinations.
    Vitale RG; Afeltra J; Dannaoui E
    Methods Mol Med; 2005; 118():143-52. PubMed ID: 15888940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Local treatment of superficial mycoses of the skin using combination drugs].
    Rieth H
    Fortschr Med; 1971 Sep; 89(27):1057-9. PubMed ID: 5170489
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fungal infections in patients with ARC with or without AIDS. Evaluation of the chemosensitivity of the isolated strains].
    Michelone G; Cavanna C; Gramegna G; Maccabruni A; Lombardi G
    G Ital Chemioter; 1987; 34(1-3):23-7. PubMed ID: 3504411
    [No Abstract]   [Full Text] [Related]  

  • 33. Phaeohyphomycotic infections in solid organ transplant patients.
    Garcia-Diaz JB; Baumgarten K
    Semin Respir Infect; 2002 Dec; 17(4):303-9. PubMed ID: 12497547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous alternariosis in a patient with systemic lupus erythematosus.
    Akman A; Sakalli Cakcak D; Ozhak Baysan B; Yazisiz V; Terzioglu E; Ciftcioglu MA; Alpsoy E
    Lupus; 2007; 16(12):993-6. PubMed ID: 18042595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of fungal infections in the immunocompromised host.
    Mahfouz T; Anaissie E
    Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scedosporium inflatum, a new pathogenic fungus. Report of 2 cases with a fatal outcome].
    Guarro J; Gaztelurrutia L; Marín J; Bárcena J
    Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):557-60. PubMed ID: 1822709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phytoeffective metabolites of Alternaria].
    Bemmann W
    Zentralbl Mikrobiol; 1986; 141(1):49-66. PubMed ID: 3518285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening South Indian medicinal plants for antifungal activity against cutaneous pathogens.
    Vonshak A; Barazani O; Sathiyamoorthy P; Shalev R; Vardy D; Golan-Goldhirsh A
    Phytother Res; 2003 Nov; 17(9):1123-5. PubMed ID: 14595602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dematiaceous fungi.
    Revankar SG
    Mycoses; 2007 Mar; 50(2):91-101. PubMed ID: 17305771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal properties of surangin B, a coumarin from Mammea longifolia.
    Deng Y; Nicholson RA
    Planta Med; 2005 Apr; 71(4):364-5. PubMed ID: 15856416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.